Colorectal Cancer Screening: Current Modalities, AI-Assisted Detection, and Persistent Gaps in Uptake
This comprehensive review surveys the landscape of colorectal cancer screening, from established invasive and non-invasive modalities to emerging AI-powered neoplasia detection during colonoscopy. While quality improvements and new technologies have enhanced screening effectiveness, overall uptake remains suboptimal, and the rising incidence among younger adults remains unexplained.
The original study
Screening and prevention of colorectal cancer.
- Authors
- Kanth P, Inadomi JM
- Journal
- BMJ (Clinical research ed.)
- Type
- Journal Article, Review
- PMID
- 34526356
Original abstract
Mortality from colorectal cancer is reduced through screening and early detection; moreover, removal of neoplastic lesions can reduce cancer incidence. While understanding of the risk factors, pathogenesis, and precursor lesions of colorectal cancer has advanced, the cause of the recent increase in cancer among young adults is largely unknown. Multiple invasive, semi- and non-invasive screening modalities have emerged over the past decade. The current emphasis on quality of colonoscopy has improved the effectiveness of screening and prevention, and the role of new technologies in detection of neoplasia, such as artificial intelligence, is rapidly emerging. The overall screening rates in the US, however, are suboptimal, and few interventions have been shown to increase screening uptake. This review provides an overview of colorectal cancer, the current status of screening efforts, and the tools available to reduce mortality from colorectal cancer.